How it works: Calming and slowing immune cells →

Tecfidera

EU: Approved in the EU since 2014US: FDA approved 2013

Molecule type
Small molecule
Mechanism (ChEMBL)
Kelch-like ECH-associated protein 1 inhibitor
Targets
Kelch-like ECH-associated protein 1
Availability
Authorised in all EU and EEA countries. Reimbursement is decided by each country.

Approvals

  • USTecfidera · Approved2013-03-27 Source
  • EU/EEATecfidera · Authorised2014-01-30 Source
  • EU/EEADimethyl fumarate Neuraxpharm · Revoked · Generic2022-05-13 Source
  • EU/EEADimethyl fumarate Polpharma · Revoked · Generic2022-05-13 Source
  • EU/EEADimethyl fumarate Mylan · Revoked · Generic2022-05-13 Source
  • EU/EEADimethyl fumarate Teva · Revoked · Generic2022-12-12 Source
  • EU/EEADimethyl fumarate Accord · Revoked · Generic2023-02-15 Source
  • EU/EEADimethyl fumarate Mylan · Authorised · Generic2024-04-22 Source
  • EU/EEADimethyl fumarate Accord · Authorised · Generic2024-04-22 Source
  • EU/EEADimethyl fumarate Neuraxpharm · Authorised · Generic2024-04-22 Source
  • EU/EEADimherity · Application withdrawn · Generic Source

Other regulatory events

  • Application withdrawn · Dimherity2022-02-22 Source
  • Revoked · Dimethyl fumarate Teva2023-12-13 Source
  • Revoked · Dimethyl fumarate Neuraxpharm2023-12-13 Source
  • Revoked · Dimethyl fumarate Accord2023-12-13 Source
  • Revoked · Dimethyl fumarate Polpharma2023-12-13 Source
  • Revoked · Dimethyl fumarate Mylan2023-12-13 Source

Safety communications

  • EMA safety letter (DHPC) · 2020-11-12

    Tecfidera: Type II variation Source

Most-reported side effects (FDA reports)

Reports to the FDA's adverse event system (FAERS) show what people and doctors reported while taking the medicine. They do not prove the medicine caused it, and they are not rates.

122,556 reports in total, 40,839 marked serious.

  • Flushing17,109
  • Nausea8,978
  • Diarrhoea8,301
  • Multiple sclerosis relapse8,128
  • Fatigue6,964
  • Multiple sclerosis5,746
  • Vomiting5,652
  • Memory impairment5,572
  • Gastric disorder5,551
  • Abdominal pain upper5,418

Trials

Key trials

Large trials with a reported result on their main goal.

Running now

  • VOYAGE

    Not yet recruiting · Phase 3 · Relapsing MS · ongoing

  • DESIRE MS

    Recruiting · Phase 3 · Relapsing and progressive · ongoing

  • TWINS

    Not yet recruiting · Phase 3 · Relapsing MS · ongoing

  • Dimethyl fumarate

    Running, not recruiting · MS (type not specified) · ongoing

  • Dimethyl fumarate

    Recruiting · Relapsing MS · ongoing

  • Dimethyl fumarate

    Running, not recruiting · Relapsing MS · ongoing

  • STOP-I-SEP

    Running, not recruiting · Phase 3 · Progressive MS · ongoing

Other trials (58)

Completed small trials, dose-finding studies and trials in other diseases.

  • TDM-MS

    Status unknown · Phase 4 · MS (type not specified) · no_result_found

  • Dimethyl fumarate, phase 4

    Completed · Phase 4 · Relapsing MS · no_result_found

  • Lympho-TEC

    Completed · Relapsing MS · result_in_paper_unread

  • Dimethyl fumarate

    Completed · Relapsing MS · no_result_found

  • STATURE

    Status unknown · MS (type not specified) · no_result_found

  • TEC-ADHERE

    Completed · Relapsing MS · result_in_paper_unread

  • Dimethyl fumarate

    Completed · MS (type not specified) · result_in_paper_unread

  • SURV-SEP

    Terminated · Phase 4 · Relapsing and progressive · stopped_other

  • PRAG-MS

    Terminated · Phase 4 · Relapsing MS · stopped_other

  • Dimethyl fumarate

    Completed · MS (type not specified) · no_result_found

For information only, not medical advice. Talk to your neurologist before changing treatment.

Hypotheses involving this medicine

Loading hypotheses…

Loading reviews and guidelines…

Lab studies

Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.

Loading lab studies…

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error